https://www.marketscreener.com/quote/stock/ESSA-PHARMA-INC-44458541/news/ESSA-Pharma-Presents-Updated-Phase-1-Masofaniten-EPI-7386-Clinical-Data-at-the-2024-ASCO-Genitouri-45814116/?utm_source=telegram&utm_medium=social&utm_campaign=share